Navigation Links
Investigating the development of mechanosensitivity

Researchers of the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have gained crucial insight into how mechanosensitivity arises. By measuring electrical impulses in the sensory neurons of mice, the neurobiologists and pain researchers Dr. Stefan G. Lechner and Professor Gary Lewin were able to directly elucidate, for the first time, the emergence of mechanosensitivity. At the same time they were able to show that neurons develop their sensitivity to touch and pain during different developmental phases but always coincidentally with the growth of the neuronal pathways. (EMBO Journal, 2009, doi:10.1038/emboj.2009.73).*

The sensory neurons, which are sensitive to touch and pain, are located in the dorsal root ganglia between the intervertebral discs. The neurons receive the stimulus and convert it into electrical signals that are conveyed to the brain.

Signal transduction has been investigated very thoroughly, which has led to the development of drugs that block the transduction of pain signals to the brain. Very little, however, is known about how stimulus sensitivity actually emerges.

Using the patch-clamp technique in isolated cells of mouse embryos, the MDC researchers succeeded in measuring tiny electrical currents in the cell membranes after a mechanosensory stimulus.

"These measurements are extremely difficult," Dr. Lechner explained, "which is why only very few laboratories in the world are specialized in this area."

The researchers in Berlin-Buch were able to show that the sensory neurons in the mouse embryo have already fully developed their mechanosensitivity competence on embryonic day 13. That corresponds to about the end of the sixth month of pregnancy in humans.

For this development the neurons do not require any nerve growth factor, which is why the researchers suspect that this process is driven by a genetic program. In contrast, the competence to sense pain in the sensory neurons can only develop with the aid of nerve growth factor (NGF). It takes place at a later stage in embryonic development and even after birth.


Contact: Barbara Bachtler
Helmholtz Association of German Research Centres

Related biology news :

1. Strong immune response to new siRNA drugs in development may cause toxic side effects
2. Development of an artificial simulator of the nervous system to do research into diseases
3. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
4. Beating heart machine expedites research and development of new surgical tools, techniques
5. $1.6 million grant to lead development of resistance-detecting field kit
6. NIH grants $122 million in Institutional Development Awards
7. Bovine genome provides clues to possible new developments
8. Researchers discover that gene switches on during development of epilepsy
9. Mouse model provides a new tool for investigators of human developmental disorder
10. Prenatal meth exposure linked to abnormal brain development
11. NIH funds development of resistance-breaking insecticides to reduce malaria transmission
Post Your Comments:
(Date:11/20/2015)... NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... recently interviewed on The RedChip Money Report ... on Bloomberg Europe , Bloomberg Asia, Bloomberg Australia, ... NXTD ) ("NXT-ID" or the "Company"), a biometric authentication ...
(Date:11/19/2015)... , Nov. 19, 2015  Based on its ... & Sullivan recognizes BIO-key with the 2015 Global Frost ... year, Frost & Sullivan presents this award to the ... catering to the needs of the market it serves. ... line meets and expands on customer base demands, the ...
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
Breaking Biology Technology: